NPI: 1366597114 · VIRGINIA BEACH, VA 23456 · Pediatrics Physician · NPI assigned 01/24/2007
Authorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
| Authorized Official | ABSHIRE, KATHRYN (SENIOR VP/CFO) |
| Parent Organization | CHILDRENS MEDICAL GROUP INC |
| NPI Enumeration Date | 01/24/2007 |
Other providers sharing the same authorized official: ABSHIRE, KATHRYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,291 | $250K |
| 2019 | 13,847 | $532K |
| 2020 | 11,993 | $418K |
| 2021 | 14,101 | $428K |
| 2022 | 17,000 | $516K |
| 2023 | 17,557 | $526K |
| 2024 | 14,538 | $547K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20,446 | 18,702 | $1.27M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7,119 | 6,597 | $648K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4,588 | 4,396 | $379K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,109 | 3,018 | $254K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2,860 | 2,560 | $222K |
| 92551 | 9,803 | 9,463 | $102K | |
| 90686 | 7,223 | 6,830 | $87K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 543 | 537 | $49K |
| 90670 | 1,377 | 1,300 | $27K | |
| 96160 | 8,617 | 8,198 | $22K | |
| 96127 | 3,694 | 3,209 | $19K | |
| 90698 | 1,036 | 976 | $16K | |
| 99199 | Unlisted special service, procedure or report | 2,184 | 1,163 | $13K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,271 | 994 | $12K |
| 99174 | 2,027 | 1,936 | $11K | |
| 90656 | 643 | 634 | $10K | |
| 99173 | 2,694 | 2,614 | $7K | |
| 99188 | 308 | 296 | $7K | |
| 90677 | 229 | 206 | $7K | |
| 96161 | 2,554 | 2,361 | $6K | |
| 90651 | 139 | 132 | $6K | |
| 90680 | 390 | 356 | $6K | |
| 90671 | 267 | 237 | $5K | |
| 1128F | 7,403 | 6,771 | $5K | |
| 90633 | 293 | 278 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 292 | 130 | $4K |
| 0072A | 63 | 51 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 70 | 64 | $2K |
| 90685 | 208 | 189 | $2K | |
| 90744 | 187 | 173 | $2K | |
| 0071A | 55 | 55 | $2K | |
| 83655 | 128 | 117 | $2K | |
| 99000 | 755 | 714 | $1K | |
| 0002A | 38 | 29 | $1K | |
| 0001A | 32 | 31 | $1K | |
| 90619 | 49 | 44 | $1K | |
| 90710 | 25 | 24 | $988.85 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 53 | 51 | $777.19 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 20 | 19 | $674.80 |
| 1127F | 418 | 395 | $600.00 | |
| 0081A | 13 | 13 | $592.40 | |
| 85018 | 189 | 164 | $427.35 | |
| 90696 | 25 | 24 | $408.84 | |
| 90734 | 12 | 12 | $294.61 | |
| 90688 | 19 | 19 | $254.75 | |
| 36416 | 848 | 783 | $197.65 | |
| 80061 | Lipid panel | 13 | 12 | $187.98 |
| 90716 | 13 | 13 | $162.40 | |
| 90715 | 14 | 13 | $158.76 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 16 | 16 | $142.96 |
| 90707 | 12 | 12 | $134.75 | |
| 94760 | 106 | 93 | $79.01 | |
| 99051 | 33 | 31 | $44.40 | |
| 91300 | 59 | 56 | $0.52 | |
| 91308 | 31 | 31 | $0.27 | |
| G9920 | Screening performed and negative | 14 | 13 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 629 | 601 | $0.00 |
| 91307 | 71 | 68 | $0.00 |